FDA Approves First Drug for MASH
Resmetirom (Rezdiffra) becomes the first FDA-approved treatment specifically for metabolic dysfunction-associated steatohepatitis.
Your comprehensive resource for understanding, preventing, and managing liver disease
Click to learn about symptoms, causes, treatments, and prevention
Liver inflammation caused by viruses, alcohol, or autoimmune conditions. Includes Hepatitis A, B, C, D, and E.
Learn More →Most common liver disease affecting 38% of adults. Often reversible with lifestyle changes if caught early.
Learn More →Late-stage scarring of the liver. Damage is permanent but progression can be slowed with treatment.
Learn More →Primary liver cancer often develops in cirrhotic livers. Early detection improves treatment outcomes.
Learn More →The immune system attacks liver cells. More common in women and treatable with immunosuppression.
Learn More →Inherited conditions like Wilson disease and hemochromatosis. Early diagnosis prevents complications.
Learn More →Excessive alcohol is a leading cause of liver disease. Follow recommended guidelines or abstain completely.
Obesity increases risk of fatty liver disease. Even 5-10% weight loss can improve liver health.
Vaccines for Hepatitis A and B can prevent these serious liver infections.
Avoid sharing needles, practice safe sex, and ensure sterile equipment for tattoos.
Uncontrolled diabetes significantly increases fatty liver disease risk.
Early detection of liver problems improves outcomes. Get screened if at risk.
Connect with others on similar journeys
Support for caregivers and loved ones
Lifestyle tips for liver health
Resmetirom (Rezdiffra) becomes the first FDA-approved treatment specifically for metabolic dysfunction-associated steatohepatitis.
Updated recommendations expand screening to all adults aged 18-79, regardless of risk factors.
Researchers discover new pathway that could enhance liver regeneration after injury.